Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference | ||
By: Nasdaq / GlobeNewswire - 19 Sep 2017 | Back to overview list |
|
GAITHERSBURG, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference.
Presentation details are as follows:
A replay of the presentation will also be accessible under the "Investors/Events" section of the Novavax website at novavax.com . About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com . Contact:
Investor Relations
Media
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Novavax, Inc. via GlobeNewswire
HUG#2135426
|
||
|
||
Copyright 2017 Nasdaq / GlobeNewswire | Back to overview list |